Effect of Preconditioned Mesenchymal Stromal Cells on Early Microvascular Disturbance in a Mouse Sepsis Model

Nathalie Baudry1, Julie Starck1,2, Clotilde Aussel3

  • 1Laboratoire d'Etude de la Microcirculation, Université Paris VII Lariboisière St-Louis, UMR 942, Paris, France.

Insights

Preconditioning mesenchymal stromal cells (MSCs) with interferon gamma (IFNγ) improved microcirculation in a mouse sepsis model. This therapy enhanced white blood cell flow and red blood cell velocity, aiding early sepsis recovery.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Critical Care Medicine

Background:

  • Sepsis often leads to multiple organ dysfunction syndrome (MODS) despite treatment, with microcirculation injury being a key factor.
  • Mesenchymal stromal cells (MSCs) show promise in sepsis models, with their efficacy potentially enhanced by preconditioning.
  • Interferon gamma (IFNγ) preconditioning of MSCs (MSC-IFNγ) boosts their immunosuppressive capabilities.

Purpose of the Study:

  • To investigate the impact of naive versus IFNγ-preconditioned MSCs on leukocyte-endothelium interactions in a polymicrobial sepsis model.
  • To assess the therapeutic effects of MSC-IFNγ on microvascular hemodynamics during early sepsis.

Main Methods:

  • A polymicrobial sepsis model was induced in mice via intraperitoneal feces injection.
  • Intravital microscopy of cremaster muscle venules was used to analyze leukocyte behavior at 6 hours post-induction.
  • Plasma analysis was performed to evaluate inflammation and endothelial activation markers.

Main Results:

  • MSC-IFNγ treatment significantly improved white blood cell (WBC) flow and increased the percentage of venules with flowing WBCs.
  • A notable reduction in WBC adhesion and an increase in average red blood cell velocity (VRBC) were observed in the MSC-IFNγ group.
  • MSC-IFNγ demonstrated a beneficial effect on microcirculation compared to naive MSCs or control.

Conclusions:

  • Intravenous administration of IFNγ-preconditioned MSCs effectively improves microvascular hemodynamics in the early stages of sepsis.
  • MSC-IFNγ therapy mitigates leukocyte-endothelium interactions, suggesting a potential therapeutic strategy for sepsis-induced organ injury.

Related Concept Videos